Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Harbor Capital Advisors Inc. lowered its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 8.9% in the fourth ...

Piper Sandler Companies (NYSE:PIPR – Get Free Report)’s stock price was down 1.4% during trading on Tuesday . The stock traded as low as $293.09 and last traded at $297.24. Approximately 150,516 ...

Fintel reports that on January 6, 2025, Goldman Sachs downgraded their outlook for Piper Sandler Companies (NYSE:PIPR) from ...

Long term Piper Sandler Companies (NYSE:PIPR) shareholders would be well aware of this, since the stock is up 248% in five years. Then again, the 8.4% share price decline hasn't been so fun for ...

Piper Sandler lowered the firm’s price target on MarketAxess (MKTX) to $240 from $265 and keeps a Neutral rating on the shares as part of an earnings preview note for earnings, trading companies ...

Piper Sandler downgraded Biogen (NASDAQ ... ESALF), slashed its sales outlook for the companies' Alzheimer's therapy, Leqembi (lecanemab), in November. The Japanese drugmaker projected ¥42.5bn ...

View Piper Sandler Companies (PIPR) current and estimated P/E ratio data provided by Seeking Alpha.

NEW YORK, January 13, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the healthcare investment ...